Learn More
Hammer et al. examined 2817 subjects, including 1325 healthy subjects and patients with schizophrenia (1081), Parkinson disease (263) and affective disorders (148) for the presence of several immunoglobulin subtypes of antibodies against the NR1 subunit of the NMDA receptor (NMDAR). In this large-scale screening, they found that 10.5% of all subjects were(More)
  • 1